Cancer Treatments / Therapy Results, Survival Rates, Toxicity, Side Effects, and Hospital information for 100s of therapies at Cancer Monthly

Cancer and Ganoderma

Posted on Tuesday, March 31, 2009

Herbal Extract Fights Drug-Resistant Lung Cancer

The Chinese herb Ganoderma kills small-cell lung cancer cells that are resistant to many chemotherapy drugs, and it may prove a life-saving addition to current cancer therapy, according to a new study in Cancer Letters.

Small-cell lung cancer is particularly difficult to treat because the cancer spreads rapidly throughout the body, rather than forming large tumors that can be removed surgically. To treat this cancer, doctors typically turn to chemotherapy, which attacks cancer cells throughout the body.

Chemotherapy can have severe side effects though, because it attacks healthy cells as well as cancerous ones. And over time, lung cancer can become resistant to the effects of chemotherapy, rendering it virtually ineffective. “The chemotherapy would still work, but you’d have to use a dose that would be so toxic that the patient could not tolerate it,” explains lead study author David Sadava, PhD, Pritzker Foundation Professor of Biology at the Keck Science Center in Claremont, California and Adjunct Professor in the Department of Molecular Medicine at the City of Hope Cancer Center in Duarte, California.

Patients who have been told their cancer is not treatable often turn to alternative therapies, including herbs. The mushroom extract Ganoderma lucidum is one of the most popular of these herbs. It is widely available in health food stores as the Japanese herbal remedy, Reishi and the Chinese herb, Ling Zhi.

Ganoderma lucidum has been studied for its effects on leukemia, as well as on cancers of the breast, bladder, colon, and prostate. For the first time, Dr. Sadava and his team set out to investigate its effects on small-cell lung cancer. They also decided to look at 20 of the more than 250 other Ganoderma species in existence, to see if they too might have a benefit.

The researchers took extracts of these herbs and tested them on three different types of cells: drug-sensitive small-cell lung cancer, drug-resistant small-cell lung cancer, and normal lung cells. They discovered that Ganoderma lucidum, as well as eight other Ganoderma species killed lung cancer cells. Cancer cells responded to the herb much in the same way as they would react to chemotherapy drugs. Yet unlike chemotherapy drugs, which can also be toxic to healthy cells, herbal extracts were more deadly to cancer cells than to normal cells, indicating that they have some ability to specifically target cancer.

Treating the cancer cells with Ganoderma extract before administering chemotherapy drugs made the cancer more sensitive to treatment, which could potentially lower the effective dose of chemotherapy enough for patients to tolerate it, Dr. Sadava says.

Ganoderma won’t replace current therapies for small-cell lung cancer, but it can work in conjunction with chemotherapy to increase its effectiveness. Dr. Sadava believes that new treatments to combat lung cancer will be available in the near future, but in the meantime, “You have to do something as a transition measure to help these patients who are dying,” he says. “This herb, which is widely available and widely used, and has no side effects that we know of, should be considered for people who have drug-resistant lung cancer, along with chemotherapy.”

If you are interested in learning more about Ganoderma talk to your licensed healthcare practitioner.

Source:
Sadava D, Still DW, Mudry RR, Kane SE. Effect of Ganoderma on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells. Cancer Letters. 2009. Epub ahead of print.

More Cancer Monthly News Stories

DISCLAIMER: The following is a summary of some of the terms & conditions for accessing the information on this website. It is provided for convenience only. For the full terms & conditions please click here. This website should not be used for diagnosing or treating a health problem or disease and it is not a substitute for professional medical advice, examination, diagnosis or treatment. You should always seek the advice of your physician or other qualified health professional before starting any new treatment or making any changes to an existing treatment. You should not delay in seeking or disregard medical advice based on information on this website. This website provides links to other websites for convenience only. Cancer Monthly is not responsible for the availability or content of these external websites, nor does Cancer Monthly endorse, warrant or guarantee the products, services or information described or offered at these other websites.